The Cooper Companies, Inc. (COO)
USD 92.39
(-2.22%)
USD 92.39
(-2.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 533.1 Million USD | 5.02% |
| 2022 | 507.6 Million USD | 0.36% |
| 2021 | 505.8 Million USD | 62.22% |
| 2020 | 311.8 Million USD | -42.97% |
| 2019 | 546.7 Million USD | 35.62% |
| 2018 | 403.1 Million USD | -6.06% |
| 2017 | 429.1 Million USD | 32.41% |
| 2016 | 324.08 Million USD | 36.93% |
| 2015 | 236.67 Million USD | -22.78% |
| 2014 | 306.48 Million USD | 0.18% |
| 2013 | 305.94 Million USD | 7.96% |
| 2012 | 283.39 Million USD | 24.54% |
| 2011 | 227.55 Million USD | 19.82% |
| 2010 | 189.91 Million USD | 26.73% |
| 2009 | 149.85 Million USD | 18.03% |
| 2008 | 126.96 Million USD | 176.89% |
| 2007 | 45.85 Million USD | -59.39% |
| 2006 | 112.9 Million USD | -16.88% |
| 2005 | 135.83 Million USD | 16.35% |
| 2004 | 116.75 Million USD | 22.58% |
| 2003 | 95.24 Million USD | 42.21% |
| 2002 | 66.97 Million USD | 22.3% |
| 2001 | 54.75 Million USD | 16.83% |
| 2000 | 46.86 Million USD | 20.8% |
| 1999 | 38.8 Million USD | 30.2% |
| 1998 | 29.8 Million USD | 15.06% |
| 1997 | 25.9 Million USD | 54.17% |
| 1996 | 16.8 Million USD | 107.41% |
| 1995 | 8.1 Million USD | 268.75% |
| 1994 | -4.8 Million USD | 79.57% |
| 1993 | -23.5 Million USD | -12.44% |
| 1992 | -20.9 Million USD | 30.79% |
| 1991 | -30.2 Million USD | -127.07% |
| 1990 | -13.3 Million USD | 8.9% |
| 1989 | -14.6 Million USD | -163.76% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 192.5 Million USD | 19.05% |
| 2024 Q2 | 161.7 Million USD | 5.62% |
| 2024 Q1 | 153.1 Million USD | 12.82% |
| 2023 Q4 | 135.7 Million USD | -10.49% |
| 2023 Q2 | 96.3 Million USD | -35.59% |
| 2023 Q3 | 151.6 Million USD | 57.42% |
| 2023 Q1 | 149.5 Million USD | 44.44% |
| 2023 FY | 533.1 Million USD | 5.02% |
| 2022 Q3 | 140.6 Million USD | 5.95% |
| 2022 Q2 | 132.7 Million USD | 1.45% |
| 2022 Q4 | 103.5 Million USD | -26.39% |
| 2022 FY | 507.6 Million USD | 0.36% |
| 2022 Q1 | 130.8 Million USD | 1.71% |
| 2021 Q1 | 133.4 Million USD | 33.27% |
| 2021 Q3 | 100.6 Million USD | -29.75% |
| 2021 Q4 | 128.6 Million USD | 27.83% |
| 2021 Q2 | 143.2 Million USD | 7.35% |
| 2021 FY | 505.8 Million USD | 62.22% |
| 2020 FY | 311.8 Million USD | -42.97% |
| 2020 Q1 | 111.1 Million USD | -24.22% |
| 2020 Q3 | 72 Million USD | 151.75% |
| 2020 Q4 | 100.1 Million USD | 39.03% |
| 2020 Q2 | 28.6 Million USD | -74.26% |
| 2019 Q4 | 146.6 Million USD | 3.09% |
| 2019 FY | 546.7 Million USD | 35.62% |
| 2019 Q1 | 110.9 Million USD | -9.62% |
| 2019 Q2 | 146.9 Million USD | 32.46% |
| 2019 Q3 | 142.2 Million USD | -3.2% |
| 2018 Q3 | 115.6 Million USD | 54.75% |
| 2018 Q2 | 74.7 Million USD | -17.18% |
| 2018 Q1 | 90.2 Million USD | -16.87% |
| 2018 FY | 403.1 Million USD | -6.06% |
| 2018 Q4 | 122.7 Million USD | 6.14% |
| 2017 Q3 | 112.8 Million USD | -3.67% |
| 2017 FY | 429.1 Million USD | 32.41% |
| 2017 Q4 | 108.5 Million USD | -3.81% |
| 2017 Q1 | 90.7 Million USD | 22.27% |
| 2017 Q2 | 117.1 Million USD | 29.11% |
| 2016 Q3 | 102.67 Million USD | 14.29% |
| 2016 FY | 324.08 Million USD | 36.93% |
| 2016 Q4 | 74.18 Million USD | -27.75% |
| 2016 Q1 | 57.39 Million USD | 35.84% |
| 2016 Q2 | 89.83 Million USD | 56.51% |
| 2015 Q3 | 50.31 Million USD | -29.14% |
| 2015 FY | 236.67 Million USD | -22.78% |
| 2015 Q4 | 42.25 Million USD | -16.02% |
| 2015 Q2 | 70.99 Million USD | -2.89% |
| 2015 Q1 | 73.1 Million USD | 85.68% |
| 2014 Q2 | 88.92 Million USD | 8.95% |
| 2014 Q4 | 39.37 Million USD | -59.23% |
| 2014 Q1 | 81.62 Million USD | 31.56% |
| 2014 FY | 306.48 Million USD | 0.18% |
| 2014 Q3 | 96.56 Million USD | 8.59% |
| 2013 Q3 | 93.6 Million USD | 14.89% |
| 2013 Q4 | 62.04 Million USD | -33.72% |
| 2013 Q1 | 68.82 Million USD | -12.86% |
| 2013 Q2 | 81.47 Million USD | 18.38% |
| 2013 FY | 305.94 Million USD | 7.96% |
| 2012 Q1 | 61.72 Million USD | -7.34% |
| 2012 FY | 283.39 Million USD | 24.54% |
| 2012 Q4 | 78.98 Million USD | 2.24% |
| 2012 Q3 | 77.25 Million USD | 18.05% |
| 2012 Q2 | 65.44 Million USD | 6.01% |
| 2011 Q3 | 45.88 Million USD | -23.85% |
| 2011 FY | 227.55 Million USD | 19.82% |
| 2011 Q4 | 66.62 Million USD | 45.18% |
| 2011 Q2 | 60.25 Million USD | 9.97% |
| 2011 Q1 | 54.79 Million USD | -12.34% |
| 2010 FY | 189.91 Million USD | 26.73% |
| 2010 Q4 | 62.5 Million USD | 21.61% |
| 2010 Q3 | 51.39 Million USD | 31.67% |
| 2010 Q2 | 39.03 Million USD | 5.56% |
| 2010 Q1 | 36.97 Million USD | -11.84% |
| 2009 Q4 | 41.94 Million USD | 23.63% |
| 2009 Q1 | 32.78 Million USD | -30.99% |
| 2009 Q3 | 33.92 Million USD | -17.67% |
| 2009 FY | 149.85 Million USD | 18.03% |
| 2009 Q2 | 41.2 Million USD | 25.71% |
| 2008 Q3 | 31.04 Million USD | 9.06% |
| 2008 Q4 | 47.5 Million USD | 53.02% |
| 2008 Q1 | 19.95 Million USD | 586.97% |
| 2008 Q2 | 28.46 Million USD | 42.68% |
| 2008 FY | 126.96 Million USD | 176.89% |
| 2007 Q2 | 10.53 Million USD | -33.19% |
| 2007 FY | 45.85 Million USD | -59.39% |
| 2007 Q4 | -4.09 Million USD | -117.32% |
| 2007 Q3 | 23.65 Million USD | 124.65% |
| 2007 Q1 | 15.76 Million USD | -29.65% |
| 2006 Q3 | 32.3 Million USD | -86.79% |
| 2006 Q1 | 33.71 Million USD | 72.73% |
| 2006 FY | 112.9 Million USD | -16.88% |
| 2006 Q4 | 22.4 Million USD | -30.63% |
| 2006 Q2 | 244.48 Million USD | 625.16% |
| 2005 Q1 | 27.69 Million USD | -14.56% |
| 2005 Q3 | 45.65 Million USD | 6.24% |
| 2005 FY | 135.83 Million USD | 16.35% |
| 2005 Q2 | 42.97 Million USD | 55.18% |
| 2005 Q4 | 19.51 Million USD | -57.25% |
| 2004 Q4 | 32.41 Million USD | 2.35% |
| 2004 Q2 | 27.82 Million USD | 11.97% |
| 2004 Q1 | 24.84 Million USD | -14.15% |
| 2004 FY | 116.75 Million USD | 22.58% |
| 2004 Q3 | 31.66 Million USD | 13.82% |
| 2003 Q1 | 19.81 Million USD | -10.73% |
| 2003 FY | 95.24 Million USD | 42.21% |
| 2003 Q3 | 25.32 Million USD | 19.73% |
| 2003 Q2 | 21.15 Million USD | 6.73% |
| 2003 Q4 | 28.94 Million USD | 14.29% |
| 2002 Q1 | 13.1 Million USD | -24.94% |
| 2002 Q2 | 14.68 Million USD | 12.02% |
| 2002 Q4 | 22.2 Million USD | 30.73% |
| 2002 FY | 66.97 Million USD | 22.3% |
| 2002 Q3 | 16.98 Million USD | 15.65% |
| 2001 Q2 | 13.63 Million USD | 41.02% |
| 2001 Q3 | 14 Million USD | 2.72% |
| 2001 Q4 | 17.46 Million USD | 24.72% |
| 2001 FY | 54.75 Million USD | 16.83% |
| 2001 Q1 | 9.66 Million USD | -31.95% |
| 2000 Q3 | 13.04 Million USD | 14.7% |
| 2000 Q4 | 14.2 Million USD | 8.84% |
| 2000 Q1 | 8.2 Million USD | -33.87% |
| 2000 FY | 46.86 Million USD | 20.8% |
| 2000 Q2 | 11.37 Million USD | 38.74% |
| 1999 Q3 | 10.9 Million USD | 13.54% |
| 1999 FY | 38.8 Million USD | 30.2% |
| 1999 Q2 | 9.6 Million USD | 62.71% |
| 1999 Q1 | 5.9 Million USD | 96.67% |
| 1999 Q4 | 12.4 Million USD | 13.76% |
| 1998 Q1 | 5.8 Million USD | -28.4% |
| 1998 Q3 | 11.1 Million USD | 13.27% |
| 1998 Q4 | 3 Million USD | -72.97% |
| 1998 FY | 29.8 Million USD | 15.06% |
| 1998 Q2 | 9.8 Million USD | 68.97% |
| 1997 Q2 | 6.3 Million USD | 53.66% |
| 1997 Q1 | 4.1 Million USD | -25.45% |
| 1997 Q4 | 8.1 Million USD | 10.96% |
| 1997 FY | 25.9 Million USD | 54.17% |
| 1997 Q3 | 7.3 Million USD | 15.87% |
| 1996 Q4 | 5.5 Million USD | 0.0% |
| 1996 Q2 | 4.1 Million USD | 141.18% |
| 1996 Q1 | 1.7 Million USD | -34.62% |
| 1996 FY | 16.8 Million USD | 107.41% |
| 1996 Q3 | 5.5 Million USD | 34.15% |
| 1995 FY | 8.1 Million USD | 268.75% |
| 1995 Q4 | 2.6 Million USD | -13.33% |
| 1995 Q3 | 3 Million USD | 100.0% |
| 1995 Q1 | 1 Million USD | 123.81% |
| 1995 Q2 | 1.5 Million USD | 50.0% |
| 1994 Q2 | -500 Thousand USD | 70.59% |
| 1994 Q4 | -4.2 Million USD | -520.0% |
| 1994 Q3 | 1 Million USD | 300.0% |
| 1994 Q1 | -1.7 Million USD | -13.33% |
| 1994 FY | -4.8 Million USD | 79.57% |
| 1993 FY | -23.5 Million USD | -12.44% |
| 1993 Q1 | -4.8 Million USD | -336.36% |
| 1993 Q2 | -5 Million USD | -4.17% |
| 1993 Q3 | -12.3 Million USD | -146.0% |
| 1993 Q4 | -1.5 Million USD | 87.8% |
| 1992 Q4 | -1.1 Million USD | 91.34% |
| 1992 Q1 | -4 Million USD | 45.95% |
| 1992 FY | -20.9 Million USD | 30.79% |
| 1992 Q2 | -3.2 Million USD | 20.0% |
| 1992 Q3 | -12.7 Million USD | -296.88% |
| 1991 Q3 | -8 Million USD | 3.61% |
| 1991 Q1 | -6.7 Million USD | 86.1% |
| 1991 Q2 | -8.3 Million USD | -23.88% |
| 1991 Q4 | -7.4 Million USD | 7.5% |
| 1991 FY | -30.2 Million USD | -127.07% |
| 1990 Q2 | 13.2 Million USD | 28.16% |
| 1990 Q4 | -48.2 Million USD | -519.13% |
| 1990 Q1 | 10.3 Million USD | 119.07% |
| 1990 FY | -13.3 Million USD | 8.9% |
| 1990 Q3 | 11.5 Million USD | -12.88% |
| 1989 Q1 | 14.3 Million USD | 103.34% |
| 1989 FY | -14.6 Million USD | -163.76% |
| 1989 Q3 | 10.7 Million USD | -25.69% |
| 1989 Q4 | -54 Million USD | -604.67% |
| 1989 Q2 | 14.4 Million USD | 0.7% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 1024.429% |
| AngioDynamics, Inc. | -97.71 Million USD | 645.549% |
| AtriCure, Inc. | -26.68 Million USD | 2097.901% |
| Avinger, Inc. | -16.63 Million USD | 3304.689% |
| Azenta, Inc. | -73.12 Million USD | 829.016% |
| BioLife Solutions, Inc. | -70.82 Million USD | 852.7% |
| Daxor Corporation | -177.07 Thousand USD | 301158.873% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 3627.66% |
| Femasys Inc. | -14.5 Million USD | 3774.419% |
| GlucoTrack, Inc. | -7.1 Million USD | 7604.223% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -28046.779% |
| Hologic, Inc. | 882.6 Million USD | 39.599% |
| ICU Medical, Inc. | 22.82 Million USD | -2235.597% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 69.827% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 5290.858% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | -1337.625% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 7825.48% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 7825.48% |
| Masimo Corporation | 136.5 Million USD | -290.549% |
| Microbot Medical Inc. | -9.85 Million USD | 5509.437% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -3532.724% |
| Merit Medical Systems, Inc. | 123.94 Million USD | -330.114% |
| Nephros, Inc. | -1.59 Million USD | 33565.16% |
| NovoCure Limited | -232.87 Million USD | 328.926% |
| NEXGEL, Inc. | -3.47 Million USD | 15432.183% |
| NEXGEL, Inc. | -3.47 Million USD | 15432.183% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 618.575% |
| OraSure Technologies, Inc. | 54.07 Million USD | -885.78% |
| Pro-Dex, Inc. | 7.17 Million USD | -7332.037% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 1323.436% |
| Predictive Oncology Inc. | -13.92 Million USD | 3929.376% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 19668.092% |
| QuidelOrtho Corporation | 139.1 Million USD | -283.249% |
| Repligen Corporation | 54.57 Million USD | -876.803% |
| Sanara MedTech Inc. | -4.21 Million USD | 12747.228% |
| STAAR Surgical Company | 28.09 Million USD | -1797.356% |
| Sharps Technology, Inc. | -10.12 Million USD | 5364.327% |
| Utah Medical Products, Inc. | 16.77 Million USD | -3077.565% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 727.176% |
| Jin Medical International Ltd. | 2.86 Million USD | -18492.65% |